• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.14% Nasdaq Down 0.35%

    Agenus Inc. (AGEN)

    -NasdaqCM
    6.82 Down 0.35(4.88%) 4:00PM EDT
    |After Hours : 6.82 0.00 (0.00%) 4:34PM EDT
    Add to Portfolio
    Prev Close:7.17
    Open:7.31
    Bid:N/A
    Ask:6.88 x 1000
    1y Target Est:13.40
    Beta:0.158917
    Next Earnings Date:N/A
    Day's Range:6.65 - 7.32
    52wk Range:2.56 - 10.16
    Volume:1,126,551
    Avg Vol (3m):1,503,660
    Market Cap:574.98M
    P/E (ttm):N/A
    EPS (ttm):-1.39
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AGEN

    Comparison

    Symbol% ChgMkt Cap
    AGENDown 4.88%574.98M
    ABPIDown 2.78%314.14K

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):44.73
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.06
    Quarterly EPS Est (Sep-15) :-0.11
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Agenus Inc., an immunotherapy company, engages in discovering and developing innovative treatments for patients with cancer and other diseases. Its treatments focus on providing therapeutic benefit through modulation of immune function. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback